VALEANT PHARMACEUTICAL NORTH AMERICA LLC

Lobbying Spend

—

Filings

Firms Hired

Active Period

2014–2016

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2016	—	4	1
2015	—	4	1
2014	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MEHLMAN CONSULTING, INC.	—	11

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	9
SENATE	9

Most frequently reported lobbying issues

Issue Code	Description	Reports
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	10
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	10
Financial Institutions/Investments/Securities	Financial Institutions/Investments/Securities	10

VALEANT PHARMACEUTICAL NORTH AMERICA LLC — Lobbying Disclosure | Poliscope